Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Sanofi (France Medicine unit)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of pharmaceuticals. The business unit produces the following pharamceutical products: Surgestone, Provames, Speciafoldine and Tredemine. Surgestone and Provames are used for women's health indications; Speciafoldine is used to treat macrocytic anemia; and Tredemine is a World Health Organization recognized essential medicine to treat tapeworm.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • France

Sanofi (France Medicine unit) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Sanofi (France Medicine unit)‘s full profile, request access.

Request full access to PitchBook

Sanofi (France Medicine unit) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Sanofi (France Medicine unit)‘s full profile, request access.

Request full access to PitchBook